November 26, 2014 /3BL Media/- More than half of the 7.2 million people living with diabetes in Turkey have a complication[1] that worsens health and are costly to treat. In 2012, treating complications accounted for 74% of total diabetes expenditures. According to the latest estimates from the International Diabetes Federation, by 2035 Turkey will have the highest absolute number of people with diabetes in Europe.<br /><br />Novo Nordisk’s newly published Blueprint for Change case study ‘Innovating Diabetes care in Turkey’ shows how investing in local research and development, training of healthcare professionals and strengthening patient self-management programmes can lower costs and improve quality of life.<br /><br />Read More: http://3blmedia.com/News/Novo-Nordisk-Case-Study-Shows-Path-Lowering-Costs-and-Improving-Diabetes-Care-Turkey<br />© 2014 | 3BL Media/Novo Nordisk | All Rights Reserved
